Cogent Biosciences-Blueprint Medicines tiff turns spicy on eve of immune drug study readout Cogent says its rare disease drug will hit a ‘home run.’ Blueprint executives think otherwise

https://www.statnews.com/2025/06/19/cogent-biosciences-blueprint-medicines-bezuclastinib-readout/